Webinar: Ethical issues in human subjects eye research when responding to a crisis: In the midst of the COVID-19 pandemic
On-demand webinar
The coronavirus SARS-COV-2 and its associated disease, COVID-19, have had profound global effects on the ability to continue scientific research involving human subjects. Investigators leading and participating in these studies need to manage new ethical, health and safety issues in the presence of this highly infectious and potentially fatal disease. Additionally, investigators must account for this major confounding factor when analyzing the research data.
This webinar will explore:
- how earlier outbreaks have shaped the response to SARS-COV-2/COVID- 19
- the ethical and safety issues specific to vision research and COVID-19
- how a major interruption or shutdown may impact experimental design and data analysis
The perspective of an institutional review board (IRB) will also be shared. Participants will leave the webinar with advice and strategies for managing the ethical, health and safety issues around conducting human studies research in the COVID-19 era.
This webinar is hosted by the Ethics and Regulations in Human Research Committee and provided at no charge. A Certificate of Attendance is provided to all attendees.
Access the on-demand webinar
Moderators
Lyndell Lim, PhD, Associate Professor and Principal Research Fellow, Centre for Eye Research Australia, University of Melbourne
Sangita P. Patel, MD, PhD, Assistant Professor, Department of Ophthalmology, University at Buffalo
Russell Woods, PhD, Associate Scientist, Schepens Eye Research Institute; Associate Professor of Ophthalmology, Harvard Medical School
Speakers
Perspectives from crises past: the SARS experience
David Lye, MBBS, FRACP, FAMS, FRCP, Associate Professor, Director, Infectious Disease Research and Training Office, National Center for Infectious Diseases, Singapore
Ethical issues specific to vision research and COVID-19
James Chodosh, MD, MPH, Clinician Scientist, Massachusetts Eye and Ear
The IRB perspective on wide-spread study shutdown
Martha F. Jones, MA, CIP, Vice President of Human Research Affairs, Mass General Brigham
Statistical considerations around analysis of disrupted studies and potential confounding from COVID-19
Traci Clemons, PhD, Senior Biostatistician and Project Leader, The Emmes Company